Oral semaglutide improved liver health, diabetes status, and lipid profile in patients with MASLD and T2D, with weight loss ...
For patients with type 2 diabetes (T2D), duodenal recellularization via electroporation therapy (ReCET), which uses ...
Oral semaglutide is currently approved under the brand name Rybelsus ® as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Based on these findings, ...
A new study is adding to evidence that GLP-1 drugs such as Novo Nordisk's semaglutide and Eli Lilly's tirzepatide could also ...
While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...
"These findings are very encouraging, suggesting that ReCET is a safe and feasible procedure that, when combined with ...
News Medical on MSN9h
Semaglutide may lower Alzheimer's risk in type 2 diabetes patientsResearchers at the Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the ...
The GLP-1 RA semaglutide was associated with a 40%-70% reduced risk for first-time diagnosis of AD in patients with type 2 diabetes, real-world data show.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback